These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32790250)

  • 1. Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression.
    Hu H; Wang Z; Tan C; Liu X; Zhang H; Li K
    Adv Clin Exp Med; 2020 Aug; 29(8):911-919. PubMed ID: 32790250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the MCL-1S protein variant following dihydroartemisinin treatment induces apoptosis in cholangiocarcinoma cells.
    Hu H; Tan C; Liu X; Luo F; Li K
    Oncol Lett; 2015 Dec; 10(6):3545-3550. PubMed ID: 26788167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].
    Cao K; Sun L; Zhang Y; Wang T; Li H; Zuo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1234-1238. PubMed ID: 30377134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8.
    Nijhuis A; Curciarello R; Mehta S; Feakins R; Bishop CL; Lindsay JO; Silver A
    Cell Tissue Res; 2017 May; 368(2):325-335. PubMed ID: 28190086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.
    Lv P; Luo YF; Zhou WY; Liu B; Zhou Z; Shi YZ; Huang R; Peng C; He ZL; Wang J; Zhang HH; Nie SD
    Kaohsiung J Med Sci; 2020 Jun; 36(6):429-440. PubMed ID: 32125086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.
    Wang S; Yadav AK; Han JY; Ahn KS; Jang BC
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway.
    Thongchot S; Vidoni C; Ferraresi A; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Mol Carcinog; 2018 Dec; 57(12):1735-1750. PubMed ID: 30136419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146b-5p suppresses cholangiocarcinoma cells by targeting TRAF6 and modulating p53 translocation.
    Ren Y; Wang X; Ji T; Cai X
    Acta Histochem; 2021 Oct; 123(7):151793. PubMed ID: 34610483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mir-29 regulates Mcl-1 protein expression and apoptosis.
    Mott JL; Kobayashi S; Bronk SF; Gores GJ
    Oncogene; 2007 Sep; 26(42):6133-40. PubMed ID: 17404574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of miR-29b on the Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells by Targeting Mcl-1 and CCND2.
    Chen J; Li Y; Li Y; Xie L; Wang J; Zhang Y; Xiao T
    Biomed Res Int; 2018; 2018():6051407. PubMed ID: 29662889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
    Okamoto K; Miyoshi K; Murawaki Y
    PLoS One; 2013; 8(10):e77623. PubMed ID: 24147037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
    Palve VC; Teni TR
    Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.
    Chen L; Yan HX; Yang W; Hu L; Yu LX; Liu Q; Li L; Huang DD; Ding J; Shen F; Zhou WP; Wu MC; Wang HY
    J Hepatol; 2009 Feb; 50(2):358-69. PubMed ID: 19070389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression.
    Cao K; Li B; Zhang YW; Song H; Chen YG; Gong YJ; Li HY; Zuo S
    Aging (Albany NY); 2021 Feb; 13(4):6055-6065. PubMed ID: 33601338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.